Amgen Inc (LTS:0R0T)
$ 269.5 0 (0%) Market Cap: 160.64 Bil Enterprise Value: 212.02 Bil PE Ratio: 38.26 PB Ratio: 21.34 GF Score: 90/100

Q4 2019 Amgen Inc Earnings Call Transcript

Jan 30, 2020 / 10:00PM GMT
Release Date Price: $224.18 (-1.57%)
Operator

My name is Ian, and I will be your conference facilitator today for Amgen's Fourth Quarter 2019 Financial Results Conference Call. (Operator Instructions)

I would now like to introduce Arvind Sood, Vice President of Investor Relations. Mr. Sood, you may now begin.

Arvind Sood
Amgen Inc. - VP of IR

Okay. Thank you, Ian, and good afternoon, everybody. Thanks for joining us today.

So 2019 was a year that we made significant progress on our strategy and took steps that positioned us well for what will surely be a special year in 2020 as we celebrate our 40th anniversary. What better gift to celebrate this important milestone than to get back to revenue growth.

So our Chairman and CEO, Bob Bradway, will lead the discussion today. We are also joined today by our new CFO, Peter Griffith, who will provide a financial update on our results for Q4 and full year 2019, and provide guidance for 2020. Our Head of Global Commercial Operations, Murdo Gordon, will then review our product performance; followed by our head of R&D, Dave Reese, who

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot